However, in gastrointestinal tract tumors, current evidences demonstrated that NDRG4 is downregulated in gastric cancers [26,29] and colorectal cancers [27,41], suggesting that it may function as a tumor suppressor. Here, NDRG4 is linked to neoplasm.